Michelle Maynard

Michelle Maynard is a Director at Scorpion Therapeutics since June 2020. Prior to this, Michelle worked as a Senior Scientist II at the same company. Michelle also gained experience as a Senior Scientist at Blueprint Medicines from October 2013 to June 2020. Before that, Michelle was a Research Supervisor at Boston Children's Hospital from June 2003 to September 2013. Michelle graduated with a Bachelor's degree in Biochemistry and Molecular Biology from Boston University in 2003. In their roles, Michelle conducts independent research projects, collaborates domestically and internationally, trains lab personnel, supervises data acquisition, manages mouse colonies and mammalian cell maintenance, places orders, maintains inventory, and archives samples.